PharmiWeb.com - Global Pharma News & Resources
20-Dec-2018

Global Paediatric Vaccine Market Outlook to 2023: A $42+ Billion Opportunity - ResearchAndMarkets.com

The "Global Paediatric Vaccine Market - Forecasts From 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

The global paediatric Vaccine market is expected to reach US$42.865 billion by 2023 from US$21.144 billion in 2017 growing at a CAGR of 12.5%.

The growth of this market may be attributed to the rising awareness among people regarding the importance of immunization.

Increase in government and non-government funding in research and development of the vaccines will also augment the market growth for paediatric vaccines during the given time frame.

However, high cost of the immunization vaccine may hamper the growth of the market during the given time frame.

Major industry players profiled as part of the report are Serum Institute of India Pvt. Ltd., Novartis AG and GlaxoSmithKline plc among others.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Paediatric Vaccine Market Forecast by Type

5.1. Monovalent

5.2. Multivalent

6. Global Paediatric Vaccine Market Forecast by Technique

6.1. Live-attenuated vaccines

6.2. Inactivated vaccines

6.3. Subunit, recombinant, polysaccharide, and conjugate vaccines

6.4. Toxoid vaccines

6.5. Others

7. Global Paediatric Vaccine Market Forecast by Application

7.1. Infectious Diseases

7.2. Cancer

7.3. Allergies

8. Global Paediatric Vaccine Market Forecast by Geography

8.1. North America

8.2. South America

8.3. Europe

8.4. Middle East and Africa

8.5. Asia Pacific

9. Competitive intelligence

9.1. Market Share Analysis

9.2. Strategies of Key Players

9.3. Recent Investments and Deals

10. Company Profiles

10.1. GlaxoSmithKline PLC

10.2. Merck Sharp & Dohme Corp.

10.3. Sanofi

10.4. Pfizer Inc.

10.5. VBI Vaccines Inc.

10.6. Serum Institute of India Pvt. Ltd.

10.7. AstraZeneca

10.8. Mitsubishi Tanabe Pharma Corporation

10.9. Novartis AG

10.10. Seqirus (CSL Limited)

For more information about this report visit https://www.researchandmarkets.com/research/qn9f7t/global_paediatric?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005804/en/

Editor Details

Last Updated: 20-Dec-2018